Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP867865.RA5uMpXX_5tzup46UQvis5yy4wRjtrrg95uGaDIS8_Vhw130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP867865.RA5uMpXX_5tzup46UQvis5yy4wRjtrrg95uGaDIS8_Vhw130_assertion type Assertion NP867865.RA5uMpXX_5tzup46UQvis5yy4wRjtrrg95uGaDIS8_Vhw130_head.
- NP867865.RA5uMpXX_5tzup46UQvis5yy4wRjtrrg95uGaDIS8_Vhw130_assertion description "[In addition, pituitary tumor-transforming gene-1 (PTTG-1) protein and mRNA levels were also decreased in thyroid cancer cells treated with CDODA-Me or CF(3)DODA-Me and this was accompanied by decreased expression of PTTG-1-dependent c-Myc and fibroblast growth factor-2 (FGF-2) genes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP867865.RA5uMpXX_5tzup46UQvis5yy4wRjtrrg95uGaDIS8_Vhw130_provenance.
- NP867865.RA5uMpXX_5tzup46UQvis5yy4wRjtrrg95uGaDIS8_Vhw130_assertion evidence source_evidence_literature NP867865.RA5uMpXX_5tzup46UQvis5yy4wRjtrrg95uGaDIS8_Vhw130_provenance.
- NP867865.RA5uMpXX_5tzup46UQvis5yy4wRjtrrg95uGaDIS8_Vhw130_assertion SIO_000772 21268135 NP867865.RA5uMpXX_5tzup46UQvis5yy4wRjtrrg95uGaDIS8_Vhw130_provenance.
- NP867865.RA5uMpXX_5tzup46UQvis5yy4wRjtrrg95uGaDIS8_Vhw130_assertion wasDerivedFrom befree-2016 NP867865.RA5uMpXX_5tzup46UQvis5yy4wRjtrrg95uGaDIS8_Vhw130_provenance.
- NP867865.RA5uMpXX_5tzup46UQvis5yy4wRjtrrg95uGaDIS8_Vhw130_assertion wasGeneratedBy ECO_0000203 NP867865.RA5uMpXX_5tzup46UQvis5yy4wRjtrrg95uGaDIS8_Vhw130_provenance.